Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 4, 2012, Pages 852-864

  Turan, R G ^a   Bozdag T , I ^a   Turan, C H ^a   Ortak, J ^a   Akin, I ^a   Kische, S ^a   Schneider, H ^a   Rauchhaus, M ^b   Rehders, T C ^a   Kleinfeldt, T ^a   Belu, C ^a   Amen, S ^a   Hermann, T ^a   Yokus, S ^c   Brehm, M ^c   Steiner, S ^c   Chatterjee, T ^a   Sahin, K ^d   Nienaber, C A ^a   Ince, H ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d Institute for Clinical Research and Statistics   (Germany)

Author keywords

Acute myocardial infarction; Cd133+; Cd34+; Ejection fraction; Freshly isolated bone marrow cell transplantation; Infarct size

Indexed keywords

LEUKOCYTE ANTIGEN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; CORONARY ANGIOGRAPHY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TRANSPLANTATION CONDITIONING;

EID: 84864489892     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01358.x     Document Type: Article

References (55)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275: 964-7.
2. Deschaseaux F, Pontikoglou C, Sensébé L. Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med. 2010; 14: 103-15.
3. Timmermans F, Plum J, Yöder MC, et al. Endothelial progenitor cells: identity defined. J Cell Mol Med. 2009; 13: 87-102.
4. + cells identifies a population of functional endothelial precursors. Blood. 2000; 95: 952-8.
5. Gunsilius E, Duba HC, Petzer A, et al. Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res. 2001; 88: E1.
6. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature. 2001; 410: 701-5.
7. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 2001; 37: 1726-32.
8. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002; 106: 3009-17.
9. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002; 106: 1913-8.
10. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004; 364: 141-8.
11. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stemcell transfer in patients with ST-segment elevation myocardial infarction: doubleblind, randomised controlled trial. Lancet. 2006; 367: 113-121.
12. Schachinger V, Erbs S, Elsasser A, et al. Inracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1210-21.
13. Yousef M, Schannwell CM, Köstering M, et al. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009; 53: 2270-2.
14. Schächinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004; 44: 1690-9.
15. Sheehan FH, Bolson EL, Dodge HT, et al. Advantages and applications of the Centreline method for characterizing regional ventricular function. Circulation. 1986; 74: 293-305.
16. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation. 2003; 107: 929-34.
17. + cell counts based o the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry. 1998; 15: 61-70.
18. Mayorga M, Finan A, Penn M. Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Stem Cell Rev. 2009; 5: 51-60.
19. Vieyra DS, Jackson KA, Goodell MA. Plasticity and tissue regenerative potential of bone marrow-derived cells. Stem Cell Rev. 2005; 1: 65-9.
20. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005; 115: 572-83.
21. Dimmeler S, Zeiher AM. Cell therapy of acute myocardial infarction: open questions. Cardiology. 2009; 113: 155-60.
22. Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010; 121: 293-305.
23. Tse HF, Chan KJY, Lo G, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear transplantation. Lancet. 2003; 361: 47-9.
24. Stamm C, Westphal B, Kleine H, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003; 361: 45-6.
25. Akar RA, Durdu S, Arat M, et al. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2009; 36: 633-43.
26. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006; 355: 1199-1209.
27. Lunde K, Solheim S, Forfang K, et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months follow-up. J Am Coll Cardiol. 2008; 51: 674-6.
28. Seeger FH, Tonn T, Krzossok N, et al. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007; 28: 766-72.
29. Turan RG, Bozdag-T I, Ortak J, et al. Improvement of cardiac function by intra coronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction. Circ J. 2011; 75: 683-91.
30. Hermann PC, Huber SL, Herrler T, et al. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant. 2008; 16: 1059-69
31. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002; 106: 2019-25.
32. Massberg S, Konrad I, Schürzinger K, et al. Platelets secrete stromal cellderived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006; 203: 1221-33.
33. Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol. 2008; 28: 208-16.
34. Lipinski MJ, Biondi-Zoccai GGL, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. J Am Coll Cardiol. 2007; 50: 1761-7.
35. Dubois C, Liu X, Claus P, et al. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol. 2010; 55: 2232-43.
36. Penn MS, Anwaruddin S, Nair R, et al. From mice to men. Commonalities in physiology for stem cell-based cardiac repair. J Am Coll Cardiol. 2009; 54: 2287-9.
37. Forrester JS, White AJ, Matsushita S, et al. New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources. J Am Coll Cardiol. 2009; 2: 1-8.
38. Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol. 2004; 44: 464-6.
39. Schächinger V, Tonn T, Dimmeler S, et al. Bone marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med. 2006; 3: 23-8.
40. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418: 41-9.
41. Kamota T, Li TS, Morikage N, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol. 2009; 53: 1814-22.
42. Turan RG, Bozdag-T I, Ortak J, et al. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev. 2010; doi: 10.1007/s12015-010-9220-8.
43. + bone marrow derived circulating progenitor cells by freshly isolated intracoronary bone marrow cells transplantation in patients with ischemic heart disease. Stem Cells Dev. 2010; doi: 10.1089/scd.2010.0373.
44. + progenitor cells after myocardial infarction. Eur J Clin Invest. 2007; 37: 842-51.
45. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function? Cell. 2001; 105: 829-41.
46. Cai X, Lin Y, Friedrich CC. et al. Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev. 2009; 5: 437-45.
47. Kong D, Melo LG, Gnecchi M, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation. 2004; 110: 2039-46.
48. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348: 593-600.
49. Urbich C, Dimmeler S. Endothelial progenitor cell: characterization and role in vascular biology. Circ Res. 2004; 95: 343-53.
50. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005; 353: 999-1007.
51. Schächinger V, Erbs S, Elsässer A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006; 27: 2775-83.
52. Katz SD, Khan T, Zeballos GA, et al. Decreased activity of the L-arginine-nitricoxide metabolic pathway in patients with congestive heart failure. Circulation. 1999; 99: 2113-7.
53. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003; 9: 1370-6.
54. Coke JP, Singer AH, Tsao P, et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992; 90: 1168-72.
55. Candipan, RC, Wang BY, Bultrago R, et al. Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol. 1996; 16: 44-50.